Sugi Predict

Sugi Predict / Targets / WDR33

WDR33

pre-mRNA 3' end processing protein WDR33 · Q9C0J8 · WDR33 on Sugi Atlas →

0 patent compounds predicted against WDR33, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to WDR33 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma PHASE2COMPLETED
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
MEHMO Natural History and Biomarkers nanRECRUITING
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Better Delineation of CDK13 Related Phenotype and Epigenetic Signature. nanUNKNOWN
Stress and Treatment Response in Puerto Rican Children With Asthma nanCOMPLETED
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature. nanUNKNOWN
Quantification of GADD34 Expression in RA nanCOMPLETED
Diagnosis of Prader-Willi Syndrome and Angelman Syndrome nanCOMPLETED
Impact of Elastin Mediated Vascular Stiffness on End Organs nanCOMPLETED
Defining the Brain Phenotype of Children With Williams Syndrome nanRECRUITING
Chromosome 5Q Gene Variants and Asthma-Related Traits nanCOMPLETED
Maternal Genes and Epimutations: Beckwith-Wiedemann Syndrome & Reproductive Risks nanRECRUITING
Child Development and Genetic Biomarkers(II): Gene Verification and Data Integration nanUNKNOWN
Phenotypic and Genotypic Characterization of Subjects With Syndromic Obesity: Identifying New Candidate Genes by Exome Sequencing (OBEXOME) nanCOMPLETED
A Retrospective and Prospective Natural History Study of Patients With WHIM Syndrome nanWITHDRAWN
Study to Investigate Genetic Causes of Severe Early Childhood Onset Obesity. nanRECRUITING
Genetic Investigation of Cancer Predisposition nanNOT_YET_RECRUITING
Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas nanACTIVE_NOT_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Finding Genes With NGS Techniques in Whom Mutations Cause Neurological Diseases nanUNKNOWN
Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
BATokines as Biomarkers of Brown Fat in Humans nanACTIVE_NOT_RECRUITING
Prognostic Value of Protein IMP3 Expression in Cervical Cancer nanCOMPLETED
Williams Syndrome (WS) and Supravalvar Aortic Stenosis (SVAS) DNA and Tissue Bank nanCOMPLETED
Using Mobile Technology to Improve Self-Regulation nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a WDR33 binder may also engage these)

ProteinNameSimilarity
Q8K4P0 — 1.000 Q8K4P0 →
SF1 Splicing factor 1 0.966 landscape →
Q64213 — 0.966 Q64213 →
Q9ULJ6 — 0.958 Q9ULJ6 →
Q6P1E1 — 0.955 Q6P1E1 →
Q640Q5 — 0.951 Q640Q5 →
P33240 — 0.950 P33240 →
Q8BIQ5 — 0.950 Q8BIQ5 →
Q58A45 — 0.950 Q58A45 →
Q8HXM1 — 0.948 Q8HXM1 →
Q5RDA3 — 0.947 Q5RDA3 →
O88874 — 0.946 O88874 →
Q8CIE2 — 0.946 Q8CIE2 →
Q8C7E9 — 0.945 Q8C7E9 →
Q9H0L4 — 0.945 Q9H0L4 →
A1L1C7 — 0.944 A1L1C7 →
Q9ERG2 — 0.944 Q9ERG2 →
SMARCE1 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 0.943 landscape →
Q9Z1X4 — 0.943 Q9Z1X4 →
ILF3 Interleukin enhancer-binding factor 3 0.941 landscape →
KHSRP Far upstream element-binding protein 2 0.941 landscape →
Q60611 — 0.941 Q60611 →
Q01826 — 0.941 Q01826 →
A5D7H2 — 0.940 A5D7H2 →
Q3UR85 — 0.940 Q3UR85 →
O54941 — 0.939 O54941 →
Q13033 — 0.939 Q13033 →
Q921F2 — 0.938 Q921F2 →
Q8UVD9 — 0.938 Q8UVD9 →
Q5R5W2 — 0.938 Q5R5W2 →